Inzy stock forecast.

Inozyme Pharma's earnings are forecast to decline at 9.3% per annum while its annual revenue is expected to grow at 95.9% per year. EPS is expected to grow by 5.5% per annum.Inozyme Pharma Stock Chart and Share Price Forecast, Short-Term "INZY" Stock Prediction for Next Days and Weeks Walletinvestor.com Inozyme Pharma Inc (INZY) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024Open $1.8900. Day Range 1.8200 - 1.9297. 52 Week Range 0.5800 - 6.7700. Market Cap $296.38M. Shares Outstanding 156.82M. Public Float 46.42M. Beta 0.48. Rev. per Employee $238.76K. P/E Ratio N/A.Find the latest eFFECTOR Therapeutics, Inc. (EFTR) stock quote, history, news and other vital information to help you with your stock trading and investing.

Oct 26, 2023 · Price Prediction forecast forIncyte to October 27, and an in-depth analysis for the week of 22 October to 28 October. Monthly forecasts INCY for 2023 with target levels, support & resistance insights to make informed investment decisions. 2022 forecast According to management , Jakafi's 2022 sales will be at $2.3-2.4 billion, implying 10% year-on-year growth. Jakafi's gross-to-net adjustment is expected at 21%.Find the latest China SXT Pharmaceuticals, Inc. (SXTC) stock quote, history, news and other vital information to help you with your stock trading and investing.

View the latest Inozyme Pharma Inc. (INZY) stock price, news, historical charts, analyst ratings and financial information from WSJ.

View live Inozyme Pharma, Inc. chart to track its stock's price action. Find market predictions, INZY financials and market news. Search. Products; Community; Markets; News; ... Market closed Market closed. No trades. See on Supercharts. Overview . News Ideas Financials Technicals Forecast . INZY chart. Today 6.22% 5 days 20.55% 1 …The Incyte Corp. stock forecast for tomorrow is $ 53.83, which would represent a 0.02% gain compared to the current price. In the next week, the price of INCY is expected to increase by 4.07% and hit $ 56.01. As far as the long-term Incyte Corp. stock forecast is concerned, here’s what our predictions are currently suggesting.View real-time stock prices and stock quotes for a full financial overview. ... Incyte’s Financial Performance and Future Outlook: An Analysis of Key Products and Revised EstimatesTipRanks | Stock Market Research, News and Analyst Forecasts ...500. Check out the ideas and forecasts on stocks from top authors of our community. They share predictions and technical outlook of the market to find trending stocks of different countries: India, USA, UK, Japan, etc. Join our financial community to start learning more about the markets. — India.

Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. 154.20M. -37.63%. Get the latest Incyte Corporation (INCY) real-time ...

2 days ago · Complete Inozyme Pharma Inc. stock information by Barron's. View real-time INZY stock price and news, along with industry-best analysis.

The Price and Consensus chart displays the company's stock price along with the consensus estimate. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The ...Find the latest Incyte Corporation (INCY) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceFind the latest SciSparc Ltd. (SPRC) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 20, 2023 · The weighted average target price per Incyte share in Dec 2023 is: 52.02. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 3.880% volatility is expected. Pessimistic target level: 51.04. Optimistic target level: 53.10. Incyte stock price predictions for 2023 using artificial intelligence. Is Inozyme Pharma Stock Undervalued? The current Inozyme Pharma share price is $3.85. The Score for INZY is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. INZY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.Incyte Corp (INCY) Stock Forecast: Potential 26.29% Increase and Next Earnings Report. On July 24, 2023, Incyte Corp (INCY) stock had a median target price forecast of $81.00, according to 16 analysts. The high estimate was $109.00, while the low estimate was $60.00. This median estimate represented a 26.29% increase from the last …

Open $1.8900. Day Range 1.8200 - 1.9297. 52 Week Range 0.5800 - 6.7700. Market Cap $296.38M. Shares Outstanding 156.82M. Public Float 46.42M. Beta 0.48. Rev. per Employee $238.76K. P/E Ratio N/A.The consensus price target of analysts on Wall Street is $21.00, which implies an increase of 81.67% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $15.00 and $40.00 respectively. As a result, INZY is trading at a discount of -938.96% off the target high and -289.61% off the low.Find the latest Inozyme Pharma, Inc. (INZY) stock quote, history, news and other vital information to help you with your stock trading and investing.Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) saw a large growth in short interest in the month of November. ... Adage Capital Partners GP L.L.C. now owns 5,537,500 shares of the company’s stock valued at $23,258,000 after buying an additional 1,287,500 shares during the last quarter. 72.03% of the stock is owned by hedge funds …American Electric Power. Cramer said that he likes the stock because the company is well-run, and utility stocks tend to perform well during economic slowdowns. Dollar Tree. While he does like the ...

Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...The stock market is poised to "zig-zag" towards record highs in December, with the S&P 500 rising 5% to 4,800, according to a Monday note from Fundstrat's Tom …

Find the latest Tantech Holdings Ltd (TANH) stock quote, history, news and other vital information to help you with your stock trading and investing.Join Seeking Alpha, the largest investing community in the world. Get stock market news and analysis, investing ideas, earnings calls, charts and portfolio analysis tools.Find the latest Moleculin Biotech, Inc. (MBRX) stock quote, history, news and other vital information to help you with your stock trading and investing.10 Stocks With Huge Catalysts on the Way. In this article, we will take a look at the 10 stocks with huge catalysts on the way. To see more such companies, go directly to 5 Stocks With Huge Catalysts on the Way. The US stock market continues to be in a see-saw mode as investors gauge and digest latest data. The latest jobs […] Yahoo | October ...Nov 27, 2023 · Incyte Corp Revenue Forecast for 2023 - 2025 - 2030. Incyte Corp's Revenue has seen impressive growth In the last three years, rising from $2.16B to $3.39B – a growth of 57.25%. In the next year, analysts believe that Revenue will reach $3.93B – an increase of 15.71%. For the next eight years, the forecast is for Revenue to grow by 16.18%. Recently. Price. 3.700. -3.39%. Webull offers INZY Ent Holdg (INZY) historical stock prices, in-depth market analysis, NASDAQ: INZY real-time stock quote data, in-depth charts, free INZY options chain data, and a fully built financial calendar to help you invest smart. Buy INZY stock at Webull.Find the latest Inozyme Pharma, Inc. (INZY) stock quote, history, news and other vital information to help you with your stock trading and investing.10 Stocks With Huge Catalysts on the Way. In this article, we will take a look at the 10 stocks with huge catalysts on the way. To see more such companies, go directly to 5 Stocks With Huge Catalysts on the Way. The US stock market continues to be in a see-saw mode as investors gauge and digest latest data. The latest jobs […] Yahoo | October ...

Earnings for Incyte are expected to grow by 28.00% in the coming year, from $3.00 to $3.84 per share. Incyte has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 6th, 2024 based off prior year's report dates. Read More.

Nov 24, 2023 · The Incyte Corporation stock price gained 0.637% on the last trading day (Friday, 24th Nov 2023), rising from $53.40 to $53.74. During the last trading day the stock fluctuated 1.08% from a day low at $53.21 to a day high of $53.78. The price has risen in 7 of the last 10 days and is up by 2.32% over the past 2 weeks.

Mar. 23, 2023, 11:25 AM. Needham analyst Joseph Stringer reiterated a Buy rating on Inozyme Pharma ( INZY – Research Report) today and set a price target of $23.00. The company’s shares opened ...Today's Inozyme Pharma news. 3 years of INZY financials and the NasdaqGS:INZY price performance over the last 3 years.Needham analyst Joseph Stringer reiterated a Buy rating on Inozyme Pharma (INZY – Research Report) today and set a price target of $23.00.The company’s shares opened today at $3.22. According ...President exercised options and sold US$65k worth of stock Jun 26. Inozyme Pharma, Inc. Announces Acceptance of First European Clinical Trial Application …Earnings Date. Feb 05, 2024 - Feb 09, 2024. Forward Dividend & Yield. N/A (N/A) Ex-Dividend Date. N/A. 1y Target Est. 74.41. Fair Value is the appropriate price for the shares of a company, based ... Follow. BOSTON, July 23, 2020 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (“Inozyme”) (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of ...Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $83.06 target price for Incyte stock stock. Today 200 Day Moving Average is the resistance level (70.22 $). 50 Day Moving Average is the resistance level (63.33 $). 2023.Is Inozyme Pharma Stock Undervalued? The current Inozyme Pharma share price is $3.85. The Score for INZY is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. INZY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.Find the latest Vyant Bio, Inc. (VYNT) stock quote, history, news and other vital information to help you with your stock trading and investing.View live Inozyme Pharma, Inc. chart to track its stock's price action. Find market predictions, INZY financials and market news. Search. Products; Community; Markets; News; ... Market closed Market closed. No trades. See on Supercharts. Overview . News Ideas Financials Technicals Forecast . INZY chart. Today 6.22% 5 days 20.55% 1 …Nov 29, 2023 · Their INZY share price targets range from $6.00 to $23.00. On average, they predict the company's stock price to reach $15.00 in the next year. This suggests a possible upside of 289.6% from the stock's current price. View analysts price targets for INZY or view top-rated stocks among Wall Street analysts. Stockinvest.us Pricing Options. Stockinvest.us has a single pricing tier and costs 19.90/month or $199/year. There is also a five-day free trial for new users to try out the software. When you first sign up for the free trial, Stockinvest.us offers 20% off a plan for up to 24 hours. Try StockInvest.us for Free!

Based on 12 Wall Street analysts offering 12 month price targets for Incyte in the last 3 months. The average price target is $82.64 with a high forecast of $93.00 and a low forecast of $63.00. The average price target represents a 53.24% change from the last price of $53.93. Highest Price Target $93.00. Average Price Target $82.64.Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Based on short-term price targets offered by 16 analysts, the average price target for Incyte comes to $75.44. The forecasts range from a low of $59.00 to a high of $93.00. The average price ...Instagram:https://instagram. best harley davidson insurancerfxixboh.cosco black friday Find the latest Troika Media Group, Inc. (TRKA) stock quote, history, news and other vital information to help you with your stock trading and investing. how to invest in startup companiesrsi divergences Find the latest Alzamend Neuro, Inc. (ALZN) stock quote, history, news and other vital information to help you with your stock trading and investing. e3 lithium stock Incyte stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Incyte analysts is $ 76.35. Today 200 Day Moving Average is the resistance level (65.46 $). 50 Day Moving Average is the resistance level (56.93 $).2022 forecast According to management , Jakafi's 2022 sales will be at $2.3-2.4 billion, implying 10% year-on-year growth. Jakafi's gross-to-net adjustment is expected at 21%.